Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2019

Long-term Clinical Outcomes For All-comer Denovo Coronary Artery Lesions Treated With Paclitaxel-Coated Balloons

Presenter: Nhung Nguyen

October 08, 2019

Presentation TCT 2019

Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration

Presenter: Robert Byrne

September 28, 2019

Presentation TCT 2019

Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions

Presenter: Sandeep Basavarajaiah

September 27, 2019

Presentation TCT 2019

Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials

Presenter: Bruno Scheller

September 27, 2019

Presentation TCT 2019

Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings

Presenter: Robert Byrne

September 26, 2019

Presentation ARCH 2019

Paclitaxel DCB: Back to the Dark Ages for PAD?

Presenter: George S. Chrysant

April 12, 2019

Presentation CIT 2019

New Drug-Coated Balloon Technologies: Limus and Beyond

Presenter: Bruno Scheller

March 28, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

Advertisement

Long-term Clinical Outcomes For All-comer Denovo Coronary Artery Lesions Treated With Paclitaxel-Coated Balloons

Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration

Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions

Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials

Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings

Paclitaxel DCB: Back to the Dark Ages for PAD?

New Drug-Coated Balloon Technologies: Limus and Beyond

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content